BostonGene alternatives and competitors
The closest alternatives to BostonGene are Caris Life Sciences, 4baseCare, GRAIL and bioAffinity Technologies.
Precision oncology company in Waltham, Massachusetts, combining sequencing in its own CAP accredited, CLIA certified laboratory with models of tumor and immune biology.
10 alternatives to BostonGene
What each product does, with its price as the vendor publishes it.
-
C
Caris Life Sciences (NASDAQ: CAI) is a precision oncology company in Irving, Texas. It profiles tumors in its own laboratories by whole exome and whole transcriptome sequencing and layers AI signatures on the results.
Price: No published price
-
4
Precision oncology company running hospital linked genomics laboratories in India, the United Arab Emirates, Nepal and the Philippines.
Price: No published price
-
G
Multi cancer early detection company (NASDAQ: GRAL). The Galleri test uses targeted methylation sequencing of cell free DNA from a blood draw, with machine learning classifiers that detect a cancer signal and predict its origin, across more than 50 cancer types.
Price: $949 per test (list price)
-
B
bioAffinity Technologies (NASDAQ: BIAF) develops noninvasive tests for lung disease, led by CyPath Lung, a laboratory developed test that pulmonologists and other physicians order for high risk patients with indeterminate pulmonary nodules.
Price: No published price
-
V
Veracyte sells genomic tests that pair a laboratory expression assay with a learned classifier, used by urologists, oncologists and endocrinologists to decide how intensively to treat a cancer or whether a thyroid nodule needs surgery.
Price: No published price
-
M
MyOme is a genomics company in Menlo Park, California, with a CLIA certified and CAP accredited laboratory, that sells whole genome screening built around integrated risk scores.
Price: No published price
-
A
Ambry Genetics is a genetic testing laboratory in Aliso Viejo, California, founded in 1999 and owned since 2025 by Tempus AI.
-
F
Foundation Medicine, based in Boston and a member of the Roche Group, runs comprehensive genomic profiling for cancer in its own laboratories.
Price: No published price
-
H
Genomics company in San Mateo, California, sequencing with its proprietary Exome+ assay in a CLIA certified, CAP accredited laboratory.
Price: No published price
-
P
Panakeia infers molecular status from routine H&E slide images, without sequencing, immunohistochemistry or additional tissue.
Price: No pricing published; clinical products and research platform both quoted, unit of charge unstated
BostonGene alternatives, answered
What are the best alternatives to BostonGene?
The closest alternatives to BostonGene are Caris Life Sciences, 4baseCare, GRAIL, bioAffinity Technologies and Veracyte. Caris Life Sciences (NASDAQ: CAI) is a precision oncology company in Irving, Texas. bioAffinity Technologies (NASDAQ: BIAF) develops noninvasive tests for lung disease, led by CyPath Lung, a laboratory developed test that pulmonologists and other physicians order for high risk patients with indeterminate pulmonary nodules. Veracyte sells genomic tests that pair a laboratory expression assay with a learned classifier, used by urologists, oncologists and endocrinologists to decide how intensively to treat a cancer or whether a thyroid nodule needs surgery.
Who are BostonGene's competitors?
BostonGene's competitors in the Diagnostics & Genomics category include Caris Life Sciences, 4baseCare, GRAIL, bioAffinity Technologies, Veracyte and MyOme.